Xiaofei Su
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Thyroid Disorders and Treatments
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
-
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Management and Research 28
- Diabetes Treatment and Management 19
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 3
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Thyroid Disorders and Treatments 2
- Co-authors
- Jianhua Ma (43 shared papers)Lei Ye (30 shared papers)Feng-fei Li (21 shared papers)Jin-dan Wu (17 shared papers)Huiqin Li (18 shared papers)Xiaocen Kong (10 shared papers)Rengna Yan (12 shared papers)Yun Hu (11 shared papers)
- Journals
- Diabetes Therapy (7 papers)Frontiers in Endocrinology (5 papers)Scientific Reports (4 papers)Experimental and Clinical Endocrinology & Diabetes (3 papers)Stem Cell Research & Therapy (2 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Xiaofei Su
48 papers receiving 598 citations
Peers
Comparison fields: 5 of 56
- Endocrinology, Diabetes and Metabolism 437
- Nephrology 31
- Physiology 31
- Aging 2
- Genetics 10
Countries citing papers authored by Xiaofei Su
This map shows the geographic impact of Xiaofei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Su more than expected).
Fields of papers citing papers by Xiaofei Su
This network shows the impact of papers produced by Xiaofei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Su. The network helps show where Xiaofei Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofei Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 45 | |
| 2 | 2015 | 32 | |
| 3 | 2016 | 30 | |
| 4 | 2017 | 27 | |
| 5 | 2015 | 26 | |
| 6 | 2018 | 26 | |
| 7 | 2021 | 25 | |
| 8 | 2018 | 23 | |
| 9 | 2019 | 22 | |
| 10 | 2019 | 20 | |
| 11 | 2019 | 20 | |
| 12 | 2020 | 17 | |
| 13 | 2020 | 17 | |
| 14 | 2016 | 16 | |
| 15 | 2022 | 16 | |
| 16 | 2017 | 14 | |
| 17 | 2016 | 13 | |
| 18 | 2017 | 13 | |
| 19 | 2018 | 13 | |
| 20 | 2020 | 13 |
About Xiaofei Su
Xiaofei Su is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Physiology, Cancer Research and Genetics, having authored 49 papers that have together received 613 indexed citations. Recurring topics across this work include Diabetes Management and Research (28 papers), Diabetes Treatment and Management (19 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers), Pluripotent Stem Cells Research (2 papers), Diabetes and associated disorders (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Thyroid Disorders and Treatments (2 papers) and Protease and Inhibitor Mechanisms (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (437 citations), Nephrology (31 citations), Physiology (31 citations), Aging (2 citations) and Genetics (10 citations). Xiaofei Su has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Jianhua Ma, Lei Ye, Feng-fei Li, Jin-dan Wu, Huiqin Li, Xiaocen Kong, Rengna Yan, Yun Hu, Xiaohua Xu and Honghong Zhu. Their work appears in journals such as Diabetes Therapy, Frontiers in Endocrinology, Scientific Reports, Experimental and Clinical Endocrinology & Diabetes and Stem Cell Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.